FCHMOVLEWHJWKU-SGXKBVARSA-N
C27H31F3N6O5 — CID 121352177
Data last refreshed: (MolForge compound catalog, from PubChem)
About FCHMOVLEWHJWKU-SGXKBVARSA-N
FCHMOVLEWHJWKU-SGXKBVARSA-N (PubChem CID 121352177) has the molecular formula C27H31F3N6O5 and a molecular weight of 576.58 g/mol. Its IUPAC name is (9S)-5-N-[(1R)-1-cyclopropyl-2,2,2-trifluoroethyl]-8-N-[4-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-5,8-dicarboxamide.
Molecular Properties
| Compound Name | FCHMOVLEWHJWKU-SGXKBVARSA-N |
|---|---|
| PubChem CID | 121352177 |
| Molecular Formula | C27H31F3N6O5 |
| Molecular Weight | 576.58 g/mol |
| Exact Mass | 576.23 |
| IUPAC Name | (9S)-5-N-[(1R)-1-cyclopropyl-2,2,2-trifluoroethyl]-8-N-[4-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-5,8-dicarboxamide |
| SMILES | CC1(C)OC[C@H](COc2ccnc(NC(=O)N3c4nc(C(=O)N[C@H](C5CC5)C(F)(F)F)ccc4N4CC[C@H]3C4)c2)O1 |
| InChI | InChI=1S/C27H31F3N6O5/c1-26(2)40-14-18(41-26)13-39-17-7-9-31-21(11-17)33-25(38)36-16-8-10-35(12-16)20-6-5-19(32-23(20)36)24(37)34-22(15-3-4-15)27(28,29)30/h5-7,9,11,15-16,18,22H,3-4,8,10,12-14H2,1-2H3,(H,34,37)(H,31,33,38)/t16-,18-,22+/m0/s1 |
| InChIKey | FCHMOVLEWHJWKU-SGXKBVARSA-N |
| XLogP | 3.71 |
| TPSA | 118.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 576.58 |
| LogP ≤ 5 | 3.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121352177 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.